104 related articles for article (PubMed ID: 28949377)
1. Structure-activity relationship of three synthesized benzimidazole-based oligosaccharides in human platelet activation.
Chang Y; Hsu WH; Yang WB; Jayakumar T; Lee TY; Sheu JR; Lu WJ; Li JY
Int J Mol Med; 2017 Nov; 40(5):1520-1528. PubMed ID: 28949377
[TBL] [Abstract][Full Text] [Related]
2. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.
Yen TL; Wu MP; Chung CL; Yang WB; Jayakumar T; Geraldine P; Chou CM; Chang CY; Lu WJ; Sheu JR
J Biomed Sci; 2016 Feb; 23():26. PubMed ID: 26887315
[TBL] [Abstract][Full Text] [Related]
3. Development of Benzimidazole Derivatives as Novel Anti-platelet Drugs.
Yao W-C; Yuan L-T; Yang W-B; Hsia C-H; Huang L-T; Lee T-Y; Sheu J-R; Lu W-J; Jayakumar T; Chen R-J
Curr Pharm Biotechnol; 2017; 18(7):594-605. PubMed ID: 28828982
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
5. Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.
Hsia CH; Jayakumar T; Sheu JR; Tsao SY; Velusamy M; Hsia CW; Chou DS; Chang CC; Chung CL; Khamrang T; Lin KC
Molecules; 2018 Feb; 23(2):. PubMed ID: 29470443
[TBL] [Abstract][Full Text] [Related]
6. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
7. Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases.
Yang CH; Hsia CW; Jayakumar T; Sheu JR; Hsia CH; Khamrang T; Chen YJ; Manubolu M; Chang Y
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463221
[TBL] [Abstract][Full Text] [Related]
8. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
Kuliopulos A; Mohanlal R; Covic L
Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets.
Liu X; Yan Y; Bao L; Chen B; Zhao Y; Qi R
Thromb Res; 2014 Nov; 134(5):1066-73. PubMed ID: 25223809
[TBL] [Abstract][Full Text] [Related]
14. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.
Hsia CW; Wu MP; Velusamy M; Hsia CH; Chou DS; Tsai CL; Hsu CY; Jayakumar T; Chung CL; Sheu JR
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104547
[TBL] [Abstract][Full Text] [Related]
15. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
Lückhoff A; Bohnert M; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
17. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory mechanisms of CME-1, a novel polysaccharide from the mycelia of Cordyceps sinensis, in platelet activation.
Chang Y; Hsu WH; Lu WJ; Jayakumar T; Liao JC; Lin MJ; Wang SH; Geraldine P; Lin KH; Sheu JR
Curr Pharm Biotechnol; 2015; 16(5):451-61. PubMed ID: 25751172
[TBL] [Abstract][Full Text] [Related]
19. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
